Related Experiment Video
Updated: Jun 5, 2026
06:22
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
[Diabetes mellitus and atherosclerosis]
1Department of Diabetes and Endocrinology, Osaka Saiseikai Nakatsu Hospital.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|January 14, 2011
Summary
Intensive glucose lowering in type 2 diabetes may have separate microvascular and macrovascular effects. The NICE Study showed benefits with rapid-acting insulin analogues, improving cardiovascular outcomes and reducing hypoglycemia.
Area of Science:
- Cardiology
- Endocrinology
- Diabetology
Background:
- Macroangiopathy, specifically atherosclerosis, is accelerated in type 2 diabetes due to multiple risk factors.
- The progression of atherosclerosis in diabetic patients is typically earlier, more pronounced, and faster than in non-diabetic individuals.
- The efficacy of antidiabetic therapies targeting normal glycated hemoglobin levels in reducing cardiovascular events in advanced type 2 diabetes remains a subject of debate.
Purpose of the Study:
- To investigate the differential effects of intensive glucose-lowering strategies on microvascular and macrovascular outcomes in patients with type 2 diabetes.
- To evaluate the cardiovascular benefits of intensive glucose-lowering therapy using rapid-acting insulin analogues, focusing on postprandial glucose control and hypoglycemia incidence.
Main Methods:
- Analysis of findings from the ACCORD Study regarding intensive glucose lowering.
- Evaluation of results from the NICE Study, comparing intensive glucose-lowering therapy with rapid-acting insulin analogues against other treatments.
- Assessment of cardiovascular outcomes, microvascular effects, macrovascular effects, postprandial glucose levels, and hypoglycemia.
Main Results:
- The ACCORD Study indicated that the microvascular and macrovascular effects of intensive glucose lowering should be assessed independently.
- The NICE Study demonstrated improved cardiovascular outcomes in patients receiving intensive glucose-lowering therapy with rapid-acting insulin analogues.
- This therapy effectively reduced postprandial glucose levels while minimizing the occurrence of hypoglycemia.
Conclusions:
- Intensive glucose-lowering strategies in type 2 diabetes require separate consideration for microvascular and macrovascular implications.
- The use of rapid-acting insulin analogues for intensive glucose control in type 2 diabetes is associated with favorable cardiovascular outcomes and reduced hypoglycemia.
- Targeting postprandial glucose levels with specific insulin analogues may offer a beneficial approach to managing cardiovascular risk in type 2 diabetes.
Related Concept Videos
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...